Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Hydroxychloroquine

Various toxicities following off-label use

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Noori YA, et al. Analysis of hydroxychloroquine adverse events in COVID-19 patients reported throughout Iraqi pharmacovigilance center in VigiBaseTM: A study based on WHO database. F1000 Research : Aug 2022. Available from: URL: 10.12688/f1000research.124441.1 Noori YA, et al. Analysis of hydroxychloroquine adverse events in COVID-19 patients reported throughout Iraqi pharmacovigilance center in VigiBaseTM: A study based on WHO database. F1000 Research : Aug 2022. Available from: URL: 10.12688/f1000research.124441.1
Metadaten
Titel
Hydroxychloroquine
Various toxicities following off-label use
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58204-y

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Antivirals

Case report

Buprenorphine

Case report

Pembrolizumab